Induction of antitumor cytotoxic T lymphocytes from the peripheral blood mononuclear cells of cancer patients using HLA-A2-restricted MAGE-3 peptide in vitro

Clinical Cancer Research

Volumn 3, Issue 12 I, 1997, Pages 2425-2430

  Fujie, Tatsuo ^a   Tanaka, Fumiaki ^a   Mori, Masaki ^a   Takesako, Kazutoh ^b   Sugimachi, Keizo ^c   Akiyoshi, Tsuyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b TAKARA SHUZO CO LTD   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; TUMOR ANTIGEN; TUMOR VACCINE;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL; PRIORITY JOURNAL; STOMACH CARCINOMA;

ANTIGENS, NEOPLASM; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HLA-A2 ANTIGEN; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; NEOPLASM PROTEINS; NEOPLASMS; PEPTIDE FRAGMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031431541     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van der Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
2. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szkora, J-P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethe, B., Lurquin, C., Brasseur, R., Chomez, P., De Backer, O., Cavenee, W., and Boon, T. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics, 40: 360-369, 1994.
3. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amer-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med., 176: 1455-1457, 1992.
4. van der Bruggen, P., Szikora, J-P., Boel, P., Wildmann, C., Somville, M., Sensi, M., and Boon, T. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanoma expressing HLA-Cw1601. Eur. J. Immunol., 24: 2134-2140, 1994.
5. Gaugler, B., Van der Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethe, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med., 179: 921-930, 1994.
6. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boel, P., De Smet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol., 24: 3038-3043, 1994.
7. Herman, J., van der Bruggen, P., Luescher, I. F., Mandruzzato, S., Romero, P., Thonnard, J., Fleischhauer, K., Boon, T., and Coulie, P. G. A peptide encoded by human gene MAGE-3 and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Immunogenetics, 43: 377-383, 1996.
8. Van Pel, A., van der Bruggen, P., Coulie, P. G., Brichard, V. G., Lethe, B., Van den Eynde, B., Uyttenhove, C., Renauld, J. C., and Boon, T. Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol. Rev., 145: 229-250, 1995.
9. Li, J., Yang, Y., Fujie, T., Baba, K., Ueo, H., Mori, M., and Akiyoshi, T. Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma. Clin. Cancer Res., 2: 1619-1625, 1996.
10. Mori, M., Inoue, H., Mimori, K., Shibuta, K., Baba, K., Nakashima, H., Haraguchi, M., Tsuji, K., Ueo, H., Barnard, G. F., and Akiyoshi, T. Expression of MAGE genes in human colorectal carcinoma. Ann. Surg., 224: 183-188, 1996.
11. Marchand, M., Weynants, P., Rankin, E., Arieti, F., Belli, F., Parmiani, G., Cascinelli, N., Bourlond, A., Vanwijck, R., Humblet, Y., Canon, J-L., Laurent, C., Naeyaert, J-M., Plagne, R., Deraemaecker, R., Knuth, A., Jager, E., Brasseur, F., Herman, J., Coulie, P. G., and Boon, T. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer, 63: 883-885, 1995.
12. Celis, E., Tsai, V., Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Gray, H. M., Sette, A., and Serra, H. M. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA, 91: 2105-2109, 1994.
13. Salagaller, M., Weber, J. S., Koenig, S., Yannelli, J. R., and Rosenberg, S. A. Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. Cancer Immunol. Immunother., 39: 105-116, 1994.
14. Jager, E., Ringhoffer, M., Karabach, J., Arand, M., Oesch, F., and Knuth, A. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo. Int. J. Cancer, 66: 470-476, 1996.
15. Valmori, D., Lienard, D., Waanders, G., Rimoldi, D., Cerottini, J-C., and Romero, P. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients. Cancer Res., 57: 735-741, 1997.
16. Tanaka, F., Fujie, T., Go, H., Baba, K., Mori, M., Takesako, K., and Akiyoshi, T. Efficient induction of anti-tumor cytotoxic T lymphocytes from a healthy donor using HLA-A2-restricted MAGE-3 peptide in vitro. Cancer Immunol. Immunother., 44: 21-26, 1997.
17. Dong, R., Kimura, A., Okubo, R., Shinagawa, H., Tamai, H., Nishimura, Y., and Sasazuki, T. HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum. Immunol., 35: 165-172, 1992.
18. Plebanski, M., Allsopp, C. E. M., Aidoo, M., Reyburn, H., and Hill, A. V. S. Induction of peptide-specific primary cytotoxic T lymphocyte responses from human peripheral blood. Eur. J. Immunol., 25: 1783-1787, 1994.
19. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
20. Tokunaga, H., Nakamura, Y., Sakata, K., Fujimori, K., Okubo, M., Sawada, K., and Sakiyama, S. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancer. Cancer Res., 47: 5616-5619, 1987.
21. Steinmam, R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9: 271-296, 1991.
22. Young, J. W., and Inaba, K. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med., 183: 7-11, 1995.
23. Hu, X., Chakraborty, N. G., Sporn, J. R., Kurtzman, S. H., Ergin, S. H., and Mukherji, B. Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine. Cancer Res., 56: 2479-2483, 1996.
24. Boon, T., Gajewski, T. F., and Coulie, P. From defined human tumor antigens to effective immunization. Immunol. Today, 16: 334-336.
25. Nanda, N. K., and Sercarz, E. E. Induction of anti-self-immunity to cure cancer. Cell, 82: 13-17, 1995.
26. Salgaller, M. L., Marincola, F. M., Cormier, J. N., and Rosenberg, S. A. Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides. Cancer Res., 56: 4749-4757, 1996.